Eton Pharma Chief Business Officer David Krempa reports disposal of 25,000 common shares valued at $1.63 millionPUBT·8 hours agoETON+1.51%
Eton Pharmaceuticals Chief Business Officer Sold Shares Worth Over $1.6MTradingView·8 hours agoETON+1.51%
Biotech Stocks At 52-Week Highs - ELOX, PRLD, ARGX, BOLD, CORTrttnews·19 hours agoPRLD-2.41%BOLD-1.33%
NewEdge Advisors LLC Grows Stake in Corcept Therapeutics Incorporated $CORTMarket Beat·20 hours agoCORT+0.81%STT+2.03%
Omeros (OMER) Turns Profitable As Fair Value Questions Come Into ViewSimplywall·1 day ago, 10:38 AMOMER+0.26%NVO+0.39%
MBX Biosciences, Inc. (NASDAQ:MBX) Given Average Rating of "Moderate Buy" by AnalystsMarket Beat·1 day ago, 01:44 AMMBX+0.09%
Amylyx Pharmaceuticals Inc (AMLX) Gets a Buy from LifeSci CapitalTip Ranks·2 days ago, 02:35 PMAMLX-1.32%
BlackRock Inc. Makes New $1.08 Billion Investment in Corcept Therapeutics Incorporated $CORTMarket Beat·2 days ago, 02:22 AMCORT+0.81%BLK+1.39%
Insider Shake-Up at Omeros as Key Director Sells Off a Chunk of SharesTip Ranks·Aug 21 at 09:09 PMOMER+0.26%
Omeros director Thomas J. Cable disposes of 15,000 common shares for $276,772.50PUBT·Aug 21 at 04:34 PMOMER+0.26%
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Director Sells $12,251,409.50 in StockMarket Beat·Aug 21 at 05:52 AMCORT+0.81%
Major Insider Move at Eton Pharmaceuticals Shakes Up Investor BuzzTip Ranks·Aug 20 at 09:13 PMETON+1.51%
Eton Pharma President and CEO Sean Brynjelsen sells USD 6.19 million in common sharesPUBT·Aug 20 at 05:26 PMETON+1.51%
Amylyx Pharmaceuticals Prices 14.09M-Share Public Offering at $35.50; Nets ~$472MTradingView·Aug 20 at 04:33 PMAMLX-1.32%
